Success Metrics

Clinical Success Rate
100.0%

Based on 16 completed trials

Completion Rate
100%(16/16)
Active Trials
3(12%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
4%
Ph not_applicable
12
48%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution13 total trials
Phase 2Efficacy & side effects
1(7.7%)
N/ANon-phased studies
12(92.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

94.1%

16 of 17 finished

Non-Completion Rate

5.9%

1 ended early

Currently Active

3

trials recruiting

Total Trials

25

all time

Status Distribution
Active(5)
Completed(16)
Terminated(1)
Other(3)

Detailed Status

Completed16
unknown3
Recruiting3
Not yet recruiting2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
25
Active
3
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (7.7%)
N/A12 (92.3%)

Trials by Status

not_yet_recruiting28%
completed1664%
unknown312%
recruiting312%
withdrawn14%

Recent Activity

Clinical Trials (25)

Showing 20 of 25 trialsScroll for more
NCT07485322Not Applicable

Burn Pit Exposure in Veterans: A Cancer Screening Pilot Study at the Inova Saville Cancer Screening & Prevention Center

Not Yet Recruiting
NCT06817889Phase 2

Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals

Recruiting
NCT07411261Not Applicable

PremaBiom: Metatranscriptomics of the Respiratory Microbiome to Predict the Occurrence of Bronchopulmonary Dysplasia in Preterm Infants

Not Yet Recruiting
NCT07298967Not Applicable

ORCHARDS-AIR Study

Recruiting
NCT02868658Not Applicable

Asymptomatic Flu Project

Completed
NCT04370119

Screening for COVID-19 and Monitoring of Serological Responses to SARS-CoV-2 in Healthcare Workers

Completed
NCT04366934

Study of the Pathogenesis of Olfactory Disorders in COVID-19

Completed
NCT04153331Not Applicable

Burden of Influenza at Emergency Department Level : BIED

Completed
NCT06389383Not Applicable

Pilot Study - Monitoring the Nasal Microbiome and Viral Respiratory Infections in Newborn Hospitalized in Neonatalogy.

Completed
NCT06594250

Study of the Nasal Intracellular Reservoir of Staphylococcus Aureus in Patients With S. Aureus Bacteremia

Recruiting
NCT04249245

Role of Nasal Dysbiosis in Parkinson Disease

Completed
NCT04469348Not Applicable

Inflammation, Intracellular Invasion and Colonization of the Nasal Mucosa by Staphylococcus Aureus

Completed
NCT05717283Not Applicable

Follow-up of the Nasal Microbiome and Viral Infections in Newborns Hospitalised in Neonatology.

Completed
NCT04557046Not Applicable

Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag Test

Unknown
NCT02352389

A Pilot Study of Influenza Viruses Isolated From Immunocompromised Children and Adolescents

Completed
NCT02828085Not Applicable

Improvement of the Etiological Diagnosis of the Pericarditis

Completed
NCT05506618Not Applicable

Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag ULTRA Test (ASPIRE-2)

Unknown
NCT03688347

Microbiome in Lung Cancer and Other Malignancies

Completed
NCT02743663

The Development of Novel Clinical Tests to Diagnose and Monitor Asthma in Preschool Children

Completed
NCT03336697

Determining the Microbiota Composition of the Middle Meatus in Parkinson's

Completed

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
25